Definitive Healthcare Corp Stock Short Ratio
| DH Stock | USD 4.25 0.15 3.66% |
Definitive Healthcare Corp fundamentals help investors to digest information that contributes to Definitive Healthcare's financial success or failures. It also enables traders to predict the movement of Definitive Stock. The fundamental analysis module provides a way to measure Definitive Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Definitive Healthcare stock.
Definitive | Short Ratio |
Definitive Healthcare Corp Company Short Ratio Analysis
Definitive Healthcare's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Definitive Healthcare Short Ratio | 9.05 X |
Most of Definitive Healthcare's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Definitive Healthcare Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Definitive Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Definitive Healthcare is extremely important. It helps to project a fair market value of Definitive Stock properly, considering its historical fundamentals such as Short Ratio. Since Definitive Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Definitive Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Definitive Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Definitive Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Definitive Healthcare Corp has a Short Ratio of 9.05 times. This is 132.05% higher than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 126.25% lower than that of the firm.
Definitive Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Definitive Healthcare's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Definitive Healthcare could also be used in its relative valuation, which is a method of valuing Definitive Healthcare by comparing valuation metrics of similar companies.Definitive Healthcare is currently under evaluation in short ratio category among its peers.
Definitive Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Definitive Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Definitive Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Definitive Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Definitive Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Definitive Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Definitive Healthcare's value.| Shares | Geode Capital Management, Llc | 2024-06-30 | 1.3 M | State Street Corp | 2024-06-30 | 1.1 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.1 M | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-06-30 | 1 M | Goldman Sachs Group Inc | 2024-06-30 | 1 M | Eagle Asset Management, Inc. | 2024-06-30 | 1 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 859.8 K | New York State Common Retirement Fund | 2024-09-30 | 748 K | B. Riley Asset Management, Llc | 2024-06-30 | 637.3 K | Advent International Lp | 2024-09-30 | 62.5 M | Massachusetts Financial Services Company | 2024-09-30 | 6.1 M |
Definitive Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 425.45 M | ||||
| Shares Outstanding | 115.52 M | ||||
| Shares Owned By Insiders | 3.91 % | ||||
| Shares Owned By Institutions | 94.77 % | ||||
| Number Of Shares Shorted | 2.72 M | ||||
| Price To Book | 0.94 X | ||||
| Price To Sales | 1.89 X | ||||
| Revenue | 251.41 M | ||||
| Gross Profit | 196.79 M | ||||
| EBITDA | (241.23 M) | ||||
| Net Income | (202.39 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 267.93 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 4.39 X | ||||
| Cash Flow From Operations | 41.19 M | ||||
| Short Ratio | 9.05 X | ||||
| Earnings Per Share | (3.03) X | ||||
| Price To Earnings To Growth | 1.03 X | ||||
| Target Price | 5.28 | ||||
| Number Of Employees | 950 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 482.89 M | ||||
| Total Asset | 1.83 B | ||||
| Retained Earnings | (227.45 M) | ||||
| Working Capital | 223.25 M | ||||
| Net Asset | 1.83 B |
About Definitive Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Definitive Healthcare Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Definitive Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Definitive Healthcare Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Definitive Healthcare Piotroski F Score and Definitive Healthcare Altman Z Score analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.03) | Revenue Per Share 2.187 | Quarterly Revenue Growth (0.04) | Return On Assets (0.01) | Return On Equity (0.55) |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.